CD14 and acute myeloid leukemia: In AML, the patients whose blasts were positive for CD14 showed a significantly smaller WBC count gap between procedures than those whose blasts were negative for CD14, as follows: 72.6 (18.3–169.6) (× 109/L) versus 86.0 (11.0–302.2) (× 109/L) (P = 0.003) (Supplementary Table S3).